Abzu and Contera Pharma expand strategic partnership - #BHHMembersInitiatives
Home News Abzu and Contera Pharma expand strategic partnership - #BHHMembersInitiatives

Abzu and Contera Pharma expand strategic partnership - #BHHMembersInitiatives

APRIL 19, 2023 BHH News
BHH member Abzu® and Contera Pharma expand their strategic partnership to add drug-target identification to their seminal RNA- and siRNAs therapeutic design platform. Contera Pharma is a Danish biotech company developing innovative small-molecule and RNA-based therapeutics to address neurological disorders. Their unique R&D model integrates their team of experienced neuroscience drug hunters with cutting-edge technology, like Abzu’s proprietary discovery engine, the QLattice®, to develop precision medicines. Abzu’s QLattice, a new class of explainable artificial intelligence with recently-patented technology, accelerates scientists’ exploration and understanding of relationships in data. Abzu and Contera Pharma initially collaborated in July 2021 to incorporate the QLattice into an RNA therapeutic design application. The application designs RNA therapeutics through parallel hypotheses testing of drug targets and individual antisense oligonucleotide (ASO) drug properties. After seeing accelerated progress on two undisclosed therapeutics currently in preclinical testing, Abzu and Contera Pharma agreed to expand their strategic partnership, adding siRNAs and target identification to the platform. "Our expanded strategic partnership is based on a three-pronged approach to strengthen our drug discovery platform: First, we run ASO drug design by automation; second, we will add siRNAs as an RNA therapeutic modality; and third, we identify novel targets with Abzu’s explainable artificial intelligence," says Kenneth Christensen, Chief Scientific Officer of Contera Pharma. "We want to turbocharge the development of RNA medicines," says Martin Kerr, Head of Business Development and Pharma Partnerships at Abzu. "With Contera Pharma, we’re designing and testing RNA medicines to multiple targets — all at once — which means that we’re breaking new ground faster than anyone else." Combined, this expanded partnership advances the companies vision to accelerate the drug discovery process by deepening the disease and disease-target understanding and at the same time accelerating rational drug design. Read more HERE.  
June 12, 2024 BHH News
Siemens Healthineers and Barcelona Health Hub sign partnership to drive breakthrough innovations for equitable, quality healthcare
This partnership opens a collaboration line between both entities to advance towards a future where medical care and technological advancements help healthcare professionals deliver high-quality care, thus achieving the best possible outcomes for patients.
Read more
June 10, 2024 BHH News
Menarini and Barcelona Health Hub join forces to promote the incorporation of digital health innovation into the healthcare field
Open collaboration and co-creation are the pillars for generating innovation in healthcare. Technological and scientific advances can be significantly accelerated when collaborative environments are fostered.
Read more
June 06, 2024 BHH News
BHH Podcast - Mediktor
BHH member Mediktor joins in this episode with CEO Cristian Pascual.  Listen to Cristian share his journey in revolutionizing healthcare through AI-driven medical triage. 
Read more
June 05, 2024 BHH News
CHV-FHSC signs a strategic alliance with Barcelona Health Hub
This alliance is to carry out joint activities to share concerns and knowledge that lead to the development of new technology projects.
Read more
June 05, 2024 BHH News
BHH ON AIR with Vodafone Business at Revolució 4.0 at Catalunya Ràdio
If you’re looking for a quick catch-up about all things related to digital health, don’t miss BHH this weekend at Catalunya Ràdio!
Read more
May 29, 2024 BHH News
Teladoc Health joins Barcelona Health Hub to support its mission to advance innovation in digital health
Teladoc Health, the world's leading virtual care company, with revenues of 2.6 billion USD in 2023, joins Barcelona Health Hub. 
Read more
May 22, 2024 BHH News
Check out the state of Digital Health in Catalonia
This is your chance to dive deep into the state of digital health in Catalonia with this elaborated by ACCIÓ, in collaboration with Barcelona Health Hub.
Read more
May 09, 2024 BHH News
Explore the 'Sandbox of the System' at the Stage Hospital de la Santa Creu i Sant Pau
Explore the Hospital de la Santa Creu i Sant Pau Stage as the latest track of the Health Revolution Congress on May 16th!
Read more
May 09, 2024 BHH News
BHH ON AIR with Fundació Sant Pau at Revolució 4.0 at Catalunya Ràdio
If you’re looking for a quick catch-up about all things related to digital health, don’t miss BHH this weekend at Catalunya Ràdio!
Read more
May 03, 2024 BHH News
Stage Biocat: New Pathways for the Adoption of Healthcare Innovation in Catalonia
Discover the Biocat morning session as part of the Health Revolution Congress on May 16th.
Read more